MX2012007166A - Composicion antiviral sinergica y su uso. - Google Patents

Composicion antiviral sinergica y su uso.

Info

Publication number
MX2012007166A
MX2012007166A MX2012007166A MX2012007166A MX2012007166A MX 2012007166 A MX2012007166 A MX 2012007166A MX 2012007166 A MX2012007166 A MX 2012007166A MX 2012007166 A MX2012007166 A MX 2012007166A MX 2012007166 A MX2012007166 A MX 2012007166A
Authority
MX
Mexico
Prior art keywords
antiviral composition
synergistic antiviral
synergistic
iota
carrageenan
Prior art date
Application number
MX2012007166A
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Marielle Koenig-Schuster
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44063696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012007166(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of MX2012007166A publication Critical patent/MX2012007166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con la carragenina iota y/o kappa en combinación con un inhibidor de neuraminidasa para el uso como un medicamento en un tratamiento profiláctico o terapéutico de un síntoma, afección o enfermedad, causado por, o asociado con, una infección por un virus de influenza.
MX2012007166A 2009-12-22 2010-12-17 Composicion antiviral sinergica y su uso. MX2012007166A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28214809P 2009-12-22 2009-12-22
PCT/EP2010/007726 WO2011076367A2 (en) 2009-12-22 2010-12-17 Synergistic antiviral composition and use thereof

Publications (1)

Publication Number Publication Date
MX2012007166A true MX2012007166A (es) 2012-07-23

Family

ID=44063696

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007166A MX2012007166A (es) 2009-12-22 2010-12-17 Composicion antiviral sinergica y su uso.

Country Status (21)

Country Link
US (1) US10022449B2 (es)
EP (1) EP2515889B1 (es)
JP (1) JP5902628B2 (es)
KR (1) KR101862415B1 (es)
CN (1) CN102652017A (es)
AU (1) AU2010335594B2 (es)
BR (1) BR112012015202B1 (es)
CA (1) CA2779532C (es)
CL (1) CL2012001695A1 (es)
DK (1) DK2515889T3 (es)
EA (1) EA022840B1 (es)
ES (1) ES2531367T3 (es)
IL (1) IL219552A (es)
MX (1) MX2012007166A (es)
NZ (1) NZ599839A (es)
PL (1) PL2515889T3 (es)
PT (1) PT2515889E (es)
SG (1) SG181421A1 (es)
SI (1) SI2515889T1 (es)
WO (1) WO2011076367A2 (es)
ZA (1) ZA201202482B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
RS58731B1 (sr) * 2014-01-22 2019-06-28 Visufarma B V Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
EP3419629A4 (en) * 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
EP3691672A1 (en) * 2017-10-06 2020-08-12 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Peptides for use in the treatment of viral infections
WO2019160261A1 (ko) * 2018-02-14 2019-08-22 (주)나노메디카 항바이러스 처리 방법, 항바이러스 필터, 및 이를 구비한 마스크
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
EP3995149A4 (en) * 2019-07-03 2023-07-19 Allis Inc. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS
EP4121038A4 (en) * 2020-03-18 2024-03-27 Encyt Technologies, Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTION AND RESPIRATORY COMPROMISE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593314B1 (en) * 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
MX2009005838A (es) 2006-12-05 2009-06-16 Marinomed Biotechnologie Gmbh Uso de carrageninas para el tratamiento de infecciones por rinovirus.
EP1930015A1 (en) * 2006-12-05 2008-06-11 Marinomed Biotechnologie GmbH Use of carrageenan for treating rhinovirus infections
WO2008147468A2 (en) * 2006-12-18 2008-12-04 Amcol International Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use
KR101571571B1 (ko) 2007-08-24 2015-11-24 마리노메드 바이오테크놀로지 게엠베하 황화 폴리사카라이드를 포함하는 항바이러스 조성물

Also Published As

Publication number Publication date
KR101862415B1 (ko) 2018-05-29
IL219552A (en) 2016-11-30
EP2515889A2 (en) 2012-10-31
EA201290373A1 (ru) 2012-11-30
EP2515889B1 (en) 2014-12-10
JP2013515022A (ja) 2013-05-02
JP5902628B2 (ja) 2016-04-13
SI2515889T1 (sl) 2015-04-30
ZA201202482B (en) 2012-12-27
AU2010335594B2 (en) 2015-05-21
SG181421A1 (en) 2012-07-30
EA022840B1 (ru) 2016-03-31
DK2515889T3 (en) 2015-03-02
PL2515889T3 (pl) 2015-05-29
IL219552A0 (en) 2012-06-28
US20120302522A1 (en) 2012-11-29
WO2011076367A3 (en) 2011-09-01
PT2515889E (pt) 2015-03-20
CA2779532C (en) 2018-05-22
US10022449B2 (en) 2018-07-17
CL2012001695A1 (es) 2013-03-08
CN102652017A (zh) 2012-08-29
AU2010335594A1 (en) 2012-05-24
BR112012015202A2 (pt) 2016-04-05
WO2011076367A2 (en) 2011-06-30
ES2531367T3 (es) 2015-03-13
CA2779532A1 (en) 2011-06-30
BR112012015202B1 (pt) 2020-12-08
NZ599839A (en) 2014-02-28
KR20120107970A (ko) 2012-10-04

Similar Documents

Publication Publication Date Title
MX2012007166A (es) Composicion antiviral sinergica y su uso.
IN2012DN02805A (es)
UA102673C2 (ru) Применение йота-каррагенана как противовирусного активного ингредиента
IN2012DN00624A (es)
PH12014501984A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
MX2011008171A (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
PH12015501156A1 (en) Pharmaceutical compositions
MY182771A (en) Viral replication inhibitors
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
SG179082A1 (en) Method for the preparation of an influenza virus
UA108072C2 (uk) Засіб для профілактики і лікування високопатогенних інфекційних захворювань
JO2581B1 (en) Aryl sulfonomides replaced
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
UA107687C2 (ru) Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен.
EP2555798A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX347911B (es) Vacuna contra virus de diarrea viral de bovinos.
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
MY172788A (en) Influenza vaccines
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
EA019080B9 (ru) α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА

Legal Events

Date Code Title Description
FG Grant or registration